| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 36,766 | $19,096 | $0.5194 | 10 Dec 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | 10 Dec 2021 | 1 | +$1,716 | 4 | Chief Commercial Officer | 14 Dec 2021, 16:16 |
| AVTX | Cerecor Inc. | 10 Jun 2021 | 1 | +$17,084 | 4 | Chief Commercial Officer | 14 Jun 2021, 17:02 |